Negative pressure wound therapy (NPWT) has become one of the most widely used advanced modalities for managing chronic diabetic foot ulcers (DFUs). Also known as vacuum-assisted closure, the technique applies controlled sub-atmospheric pressure across a sealed foam or gauze dressing, drawing away excess exudate while mechanically stimulating the wound bed. Because DFUs are a leading cause of hospitalization and lower-limb amputation in people with diabetes, understanding what the evidence does and does not support about NPWT is clinically important for patients, caregivers, and the wound-care teams who treat them.
How Negative Pressure Wound Therapy Works
An NPWT system consists of a fenestrated drainage tube embedded in a foam or gauze dressing, sealed with an adhesive film and connected to a pump that maintains negative pressure, typically in the range of 75 to 125 mm Hg. The applied pressure is thought to promote healing through several mechanisms: removal of interstitial fluid and inflammatory mediators, reduction of local edema, improvement of blood perfusion to the wound margins, and mechanical deformation of the tissue that encourages cell proliferation and the formation of healthy granulation tissue.
A 2023 randomized controlled trial published in the Saudi Medical Journal offered a mechanistic look at these effects. In patients with chronic DFUs prepared for split-thickness skin grafting, NPWT was associated with increased wound blood perfusion, reduced neutrophil extracellular trap formation, and a shift of wound macrophages from the pro-inflammatory M1 phenotype toward the reparative M2 phenotype—biological changes consistent with a wound bed moving out of chronic inflammation and toward repair.
Evidence on Healing and Granulation
Multiple systematic reviews and meta-analyses over the past decade have examined whether these mechanistic advantages translate into better clinical outcomes. A 2021 meta-analysis in Annals of Palliative Medicine pooled nine randomized controlled trials involving 943 patients and found that NPWT was associated with a significantly higher wound-healing rate than standard care (odds ratio 3.60) and a markedly shorter time to granulation tissue formation, with no significant increase in adverse events.
A 2024 systematic review and meta-analysis in Wounds reviewed 14 studies and reported that NPWT favored both complete wound healing and greater wound-area reduction compared with alternative interventions, though the authors noted methodological limitations and clinical heterogeneity among the included trials. Individual randomized studies have echoed these findings. A trial published in Diabetes & Metabolic Syndrome in 2021 randomized 45 patients with Wagner grade 1 and 2 ulcers and found that complete healing at three months occurred in roughly 91% of the NPWT group versus 26% of those receiving conventional saline dressings, alongside faster granulation and a shorter hospital stay.
Impact on Amputation, Infection, and Hospital Stay
Because the ultimate goal of DFU care is limb preservation, outcomes beyond simple wound closure matter. A 2025 systematic review and meta-analysis in the Journal of Wound, Ostomy and Continence Nursing analyzed 12 studies—eight clinical trials and four observational studies—and concluded that NPWT significantly improved time to granulation tissue formation, reduced hospital length of stay, and lowered the risk of secondary amputation, infection, and pain compared with conventional therapy. The authors recommended incorporating NPWT as a standard component of DFU management.
It is worth noting that not every analysis shows benefit across every endpoint. Several reviews, including a 2024 literature review in Current Diabetes Reviews, found NPWT to be more efficacious than conventional or advanced moist dressings for healing while reporting no significant difference in complications such as amputation, bleeding, or pain. Differences in study design, ulcer grade, pressure settings, and comparison dressings likely explain some of this variability.
Practical Considerations and Limitations
NPWT is not a substitute for the foundational elements of diabetic foot care. Effective treatment still depends on adequate debridement, pressure offloading, management of infection, correction of ischemia, and glycemic control. NPWT is generally most appropriate for wounds with a clean, adequately perfused base and is often used to prepare wounds for surgical closure or grafting rather than as a stand-alone cure. Contraindications and cautions include untreated osteomyelitis, exposed vessels, malignancy in the wound, and inadequate perfusion. Reviewers also consistently emphasize that negative-pressure settings should be maintained and adjusted carefully to avoid bleeding or tissue trauma.
Key Takeaways
Across a decade of randomized trials and pooled analyses, NPWT is consistently associated with faster granulation tissue formation, greater wound-area reduction, shorter hospital stays, and—in several meta-analyses—reduced rates of amputation and infection in diabetic foot ulcers. The strength of the evidence is tempered by heterogeneity in study design and wound severity, and NPWT works best as one component of comprehensive, multidisciplinary foot care rather than in isolation. For appropriately selected wounds, however, the accumulated data support it as a valuable tool in the effort to heal DFUs and preserve limbs.
References
Rodríguez Angulo A, Caballero-Alvarado J, Sarmiento-Falen J, Zavaleta-Corvera C. Comparative Assessment of Negative Pressure Wound Therapy Versus Standard Treatment in Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis. Journal of Wound, Ostomy and Continence Nursing. 2025;52(3):227–238.
Chen L, Zhang S, Da J, et al. A systematic review and meta-analysis of efficacy and safety of negative pressure wound therapy in the treatment of diabetic foot ulcer. Annals of Palliative Medicine. 2021;10(10):10830–10839.
Dalmedico MM, do Rocio Fedalto A, Martins WA, et al. Effectiveness of negative pressure wound therapy in treating diabetic foot ulcers: a systematic review and meta-analysis of randomized controlled trials. Wounds. 2024;36(8):281–289.
Maranna H, Lal P, Mishra A, et al. Negative pressure wound therapy in grade 1 and 2 diabetic foot ulcers: A randomized controlled study. Diabetes & Metabolic Syndrome. 2021;15(1):365–371.
Wu Y, Shen G, Hao C. Negative pressure wound therapy (NPWT) is superior to conventional moist dressings in wound bed preparation for diabetic foot ulcers: A randomized controlled trial. Saudi Medical Journal. 2023;44(10):1020–1029.
Widigdo DAM, Sofro ZM, Pangastuti HS, Dachlan I. The Efficacy of Negative Pressure Wound Therapy (NPWT) on Healing of Diabetic Foot Ulcers: A Literature Review. Current Diabetes Reviews. 2024;20(8):e-pub.
Comments
